by
Joan Trombetti, Writer | March 20, 2009
Edwards Lifesciences Corporation, the world leader in the science of heart valves, announced that the District Court of Dusseldorf, Germany, determined that it does not infringe on Cook Inc.'s German transcatheter valve patent.
A counter-suit by Edwards claiming invalidity of Cook's German patent is expected to be heard in Munich in 2010. Edwards has a separate lawsuit against Cook in the United Kingdom that challenges the validity of Cook's UK transcatheter valve patent. Cook has counter-sued there, claiming infringement. That case is scheduled to be heard in May.
About Edwards Lifesciences
Ad Statistics
Times Displayed: 185210
Times Visited: 4594 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring, with more than five decades of experience in partnering with clinicians to develop life-saving innovations. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies, which are sold in approximately 100 countries. The company's global brands include Carpentier-Edwards, Cosgrove-Edwards, Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.
